ArticleScientific reports2025
Exploring bacterial cellulose as an engineered living and programmable biomaterial across disciplines through qualitative thematic analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Peculiarities of Bacterial Cellulose.Polymers · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial cellulose is an engineered living material which holds significant potential due to its material properties and broad applicability across scientific and design disciplines. However, challenges in interdisciplinary collaboration, scalability and commercialization have slowed its widespread adoption and integration into industry applications such as fashion and textiles. This study addresses the gap in understanding how bacterial cellulose is perceived, developed, and utilized across scientific and design disciplines. Through 20 semi-structured interviews with scientists and designers around the world, this paper explores the following themes: (1) the human-living material relationship spectrum, which highlights the distinct ways science and design stakeholders interact with bacterial cellulose as a living material; (2) perceptions of a living material made from bacteria; and (3) bacterial cellulose's potential as a programmable biomaterial. Additionally, we employ Bruno Latour's Actor-Network Theory to map the complex network of human and non-human actors shaping bacterial cellulose's trajectory, identifying critical factors such as consumer acceptance, interdisciplinary collaboration, and material culture. By bridging perspectives from science and design, this study offers actionable insights into bacterial cellulose's future as a sustainable and programmable engineered living material, guiding its responsible development and broader adoption across industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.